Monthly lists of letters for healthcare professionals on the safety of medicines
3 August 2011
Letters sent to healthcare professionals in July 2011 to inform of new safety information and advice.
| Date issued | Product | Safety information |
|---|---|---|
| 18 July 2011 | Cardioxane (dexrazoxane) | Restricted use (30Kb) |
| 28 July 2011 | Thyrogen (thyrotropin alfa) | Update on supply and treatment recommendations (63Kb) |
| 29 July 2011 | Actos, Competact (pioglitazone) | Small increased risk of bladder cancer (77Kb) |
| 29 July 2011 | Multaq (dronedarone) | Information following preliminary study results showing increased cardiovascular risk (1057Kb) |
